PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32566254-5	2020	Inhibitors of Kdm6a and Kdm6b robustly abolished Zol-enhanced interleukin 1beta synthesis and secretion from macrophages.	Zoledronic Acid	49-52	KDM1 lysine (K)-specific demethylase 6B	Mus musculus	24-29	
32566254-6	2020	When Kdm6a and Kdm6b were pharmacologically inhibited in vivo, poor healing of the alveolar socket and inflammatory responses were ameliorated in Zol-treated mice.	Zoledronic Acid	146-149	KDM1 lysine (K)-specific demethylase 6B	Mus musculus	15-20	
32566254-7	2020	Taken together, we showed the pathologic role of Kdm6a and Kdm6b in Zol-promoted inflammatory responses and demonstrated that Kdm6a and Kdm6b are potential therapeutic targets for the treatment of BRONJ.	Zoledronic Acid	68-71	KDM1 lysine (K)-specific demethylase 6B	Mus musculus	59-64	
32566254-7	2020	Taken together, we showed the pathologic role of Kdm6a and Kdm6b in Zol-promoted inflammatory responses and demonstrated that Kdm6a and Kdm6b are potential therapeutic targets for the treatment of BRONJ.	Zoledronic Acid	68-71	KDM1 lysine (K)-specific demethylase 6B	Mus musculus	136-141